Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from STE

7 Stocks Worth Buying the Dip in Now... Or At Least Adding to Your Watchlist

While the S&P 500 notched another record close on Tuesday, 17 NYSE and Nasdaq Composite stocks fell to new 52-week lows. Here’s why the seven highest-priced names deserve a spot on your watchlist.

Barchart

STERIS' Q4 2026 Earnings: What to Expect

STERIS will release its fourth-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth.

Barchart

Is STERIS Stock Underperforming the Nasdaq?

STERIS has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Wall Street Bullish or Bearish on STERIS Stock?

Despite STERIS' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

STERIS Earnings Preview: What to Expect

STERIS is set to report its third-quarter earnings soon, and analysts are anticipating a single-digit growth in its bottom line.

Barchart

Is STERIS Stock Outperforming the S&P 500?

STERIS has outperformed the S&P 500 over the past year, and analysts are cautiously optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on STERIS Stock?

Despite STERIS' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

What You Need to Know Ahead of STERIS’ Earnings Release

STERIS is scheduled to release its second-quarter results next month, and analysts are anticipating a robust double-digit increase in earnings.

Barchart

How Is STERIS’ Stock Performance Compared to Other Medical Devices Stocks?

STERIS has outpaced its industry peers over the past year, and analysts are reasonably bullish on its future prospects.

Barchart

What Are Wall Street Analysts' Target Price for STERIS Stock?

While STERIS has underperformed the broader market over the past year, analysts are highly optimistic about the stock’s prospects.

Barchart

What to Expect From STERIS' Next Quarterly Earnings Report

STERIS is set to report its second-quarter results next month, and analysts are projecting a double-digit rise in earnings.

Barchart

STERIS Stock: Is STE Outperforming the Healthcare Sector?

STERIS has outpaced the broader healthcare sector over the past year and analysts are reasonably bullish on its future prospects.

Barchart

STERIS Stock: Is Wall Street Bullish or Bearish?

Despite STERIS’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a highly optimistic outlook on the stock’s prospects.

Barchart

What to Expect From STERIS’ Q4 2025 Earnings Report

STERIS is all geared to report its fourth-quarter results next month, and analysts project its earnings to increase by a single digit.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is STERIS Stock Underperforming the Dow?

Despite STERIS’ underperformance relative to Dow Jones over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

STERIS Stock: Analyst Estimates & Ratings

STERIS has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

StockNews.com

3 Specialty Healthcare Providers Addressing Niche Markets

The healthcare industry is poised for growth driven by the rapid adoption of new and advanced medical technologies to enhance diagnosis. Hence, investors might consider investing in healthcare stocks, such as Agilent Technologies (A), BioNTech (BNTX), and STERIS (STE), which address niche markets. Read more….

Barchart

Here's What to Expect from STERIS’ Next Earnings Report

Healthcare major STERIS is expected to announce its third-quarter earnings in the upcoming month and analysts expect a modest single-digit growth in earnings.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Is STERIS Stock Underperforming the Nasdaq?

STERIS stock has significantly underperformed the Nasdaq over the past 52 weeks, yet analysts remain strongly bullish on the stock’s prospects.

StockNews.com

3 Healthcare Technology Companies Revolutionizing Patient Care

The healthcare technology market is well-poised for long-term growth, thanks to the growing demand for medical devices, cutting-edge technologies, and changing patient care systems. Thus, it could be wise to buy fundamentally solid healthcare technology stocks Zimmer Biomet Holdings (ZBH), STERIS (STE), and Tactile Systems Technology (TCMD), which are revolutionizing…

Barchart

Do Wall Street Analysts Like STERIS Stock?

Despite STERIS’ underperformance relative to the broader market over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.

Barchart

Earnings Preview: What to Expect From STERIS' Report

STERIS will release its second-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

Barchart

Is STERIS Stock Underperforming the S&P 500?

STERIS has underperformed the S&P 500 over the past year, yet analysts remain moderately bullish about the stock’s potential.

StockNews.com

3 MedTech Stocks Revolutionizing Healthcare

MedTech stocks are at the forefront of revolutionizing healthcare with the dynamic growth potential of technology. Amid this backdrop, it could be wise to consider investing in companies like Medtronic (MDT), STERIS (STE), and Hologic (HOLX), which are transforming the way healthcare is delivered and tailoring it to individual patient…

StockNews.com

3 Healthcare Innovators Transforming Patient Care

The healthcare industry's long-term growth is fueled by rising R&D initiatives and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid medical device stocks Alcon (ALC), Becton, Dickinson and Company (BDX), and STERIS (STE) for potential returns. Keep reading.

1 2

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

United States

369,706 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.